An in vitro assessment of anti-SARS-CoV-2 activity of oral preparations of iodine complexes (RENESSANS)
Preprint
- 29 June 2020
- preprint
- Published by Cold Spring Harbor Laboratory
Abstract
Since the emergence of CoVID-19 pandemic in China in late 2019, scientists are striving hard to explore non-toxic, viable anti-SARS-CoV-2 compounds or medicines. We determined In Vitro anti-SARS-CoV-2 activity of oral formulations (syrup and capsule) of an Iodine-complex (Renessans). A monolayer of vero cells were exposed to SARS-CoV-2 in the presence and absence of different concentrations (equivalent to 50, 05 and 0.5 μg/ml of I2) of Renessans. Anti-SARS-CoV-2 activity of each of the formulation was assessed in the form of cell survival, SARS-CoV-2-specific cytopathic effect (CPE) and genome quantization. With varying concentrations of syrup and capsule, a varying rate of inhibition of CPE, cells survival and virus replication was observed. Compared to 0.5 μg/ml concentration of Renessans syrup, 5 and 50 μg/ml showed comparable results where there was a 100% cell survival, no CPEs and a negligible viral replication (ΔCT= 0.11 and 0.13, respectively). This study indicates that Renessans, containing iodine, may have potential activity against SARS-CoV-2 which needs to be further investigated in human clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Prejudice in science – Lessons from the coronavirus storyPhysica Medica, 2020
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort studyJournal of Infection, 2020
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main proteaseCell Research, 2020
- COVID-19: an update on diagnostic and therapeutic approachesBMB Reports, 2020
- Ongoing Clinical Trials for the Management of the COVID-19 PandemicTrends in Pharmacological Sciences, 2020
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Virology, Epidemiology, Pathogenesis, and Control of COVID-19Viruses, 2020
- The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the statusMilitary Medical Research, 2020
- What next for the coronavirus response?The Lancet, 2020
- The Role of the Status of Selected Micronutrients in Shaping the Immune FunctionEndocrine, Metabolic & Immune Disorders - Drug Targets, 2019